August 4, 2026 · earnings
SUPN earnings: a negative outcome, -6.0%
On August 4, 2026, SUPERNUS PHARMACEUTICALS, INC. reached its earnings. The result was a negative outcome, and the stock moved -6.0% in the window around the event. It had already run -7.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$46.00
1d before
$43.25
Event day
$46.91
1d after
$47.64
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+0.6% expected); the stock actually moved -6.0%. Model confidence at the time: 40%.
See the full scored track recordPre-catalyst setup
-7.1%
30-day run-up
3462%
30-day volatility
5.1×
volume spike